Inflammatory Response Research Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $150K

Inflammatory Response Research General Information

Description

Operator of a drug development company intended for inflammatory disorders. The company's drug development service focuses on pharmaceutical products for the treatment of inflammatory disorders and conditions and its products are the oral combination of levocetirizine and montelukast for the treatment of influenza, enabling patients to recover inflammatory disorders.

Contact Information

Website
www.irrinc.net
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • 515 East Micheltorena
  • Suite G
  • Santa Barbara, CA 93103
  • United States
+1 (805) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inflammatory Response Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 18-Dec-2018 $150K 000 Completed Generating Revenue
3. Later Stage VC (Series B) 20-Nov-2017 00000 00.000 0000 Completed Generating Revenue
2. Later Stage VC 04-Oct-2016 $15K $875K Completed Generating Revenue
1. Early Stage VC (Series A) 02-Dec-2014 $860K $860K 00.000 Completed Generating Revenue
To view Inflammatory Response Research’s complete valuation and funding history, request access »

Inflammatory Response Research Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 000,000 00.000000 00 00 00 00 0.000
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view Inflammatory Response Research’s complete cap table history, request access »

Inflammatory Response Research Executive Team (2)

Name Title Board Seat Contact Info
Chandler May MD Chief Executive Officer
Loriel May Co-Founder, Board Member & Chief Financial Officer
To view Inflammatory Response Research’s complete executive team members history, request access »

Inflammatory Response Research FAQs

  • When was Inflammatory Response Research founded?

    Inflammatory Response Research was founded in 2011.

  • Who is the founder of Inflammatory Response Research?

    Loriel May is the founder of Inflammatory Response Research.

  • Who is the CEO of Inflammatory Response Research?

    Chandler May MD is the CEO of Inflammatory Response Research.

  • Where is Inflammatory Response Research headquartered?

    Inflammatory Response Research is headquartered in Santa Barbara, CA.

  • What industry is Inflammatory Response Research in?

    Inflammatory Response Research’s primary industry is Drug Discovery.

  • Is Inflammatory Response Research a private or public company?

    Inflammatory Response Research is a Private company.

  • What is Inflammatory Response Research’s current revenue?

    The current revenue for Inflammatory Response Research is 000000.

  • How much funding has Inflammatory Response Research raised over time?

    Inflammatory Response Research has raised $2M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »